<?xml version='1.0' encoding='utf-8'?>
<document id="10418968"><sentence text="Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential." /><sentence text="Cryopreserved human hepatocytes were extensively characterized in our laboratory" /><sentence text=" The post-thaw viability, measured via dye exclusion, ranged from 55 to 83%, for hepatocytes cryopreserved from 17 donors" /><sentence text=" Post-thaw viability and yield (viable cells per vial) were found to be stable up to the longest storage duration evaluated of 120 days" /><sentence text=" Drug-metabolizing enzyme activities of the cryopreserved hepatocytes (mean of ten donors) as percentages of the freshly isolated cells were: 97%, for cytochrome P450 isoform (CYP) 1A2, 78% for CYP2A6, 96% for CYP2C9" /><sentence text=" 86% for CYP2Cl9, 90% for CYP2D6, 164% for CYP3A4, 76% for UDP-glucuronidase, and 88% for umbelliferone sulfotransferase"><entity charOffset="90-103" id="DDI-PubMed.10418968.s6.e0" text="umbelliferone" /></sentence><sentence text=" Known species-differences in 7-ethoxycoumarin (7-EC) metabolism were reproduced by cryopreserved hepatocytes from human, rat, rabbit, dog, and monkey, illustrating the utility of cryopreserved hepatocytes from multiple animal species in the evaluation of species-differences in drug metabolism"><entity charOffset="30-46" id="DDI-PubMed.10418968.s7.e0" text="7-ethoxycoumarin" /><entity charOffset="48-52" id="DDI-PubMed.10418968.s7.e1" text="7-EC" /><pair ddi="false" e1="DDI-PubMed.10418968.s7.e0" e2="DDI-PubMed.10418968.s7.e0" /><pair ddi="false" e1="DDI-PubMed.10418968.s7.e0" e2="DDI-PubMed.10418968.s7.e1" /></sentence><sentence text=" Higher throughput screening (HTS) assays were developed using cryopreserved human hepatocytes for hepatotoxicity, metabolic stability, and inhibitory drug-drug interactions" /><sentence text=" Dose-dependent cytotoxicity, measured using MTT metabolism as an endpoint, was observed for the known hepatotoxic chemicals tamoxifen, clozapine, cadmium chloride, diclofenac, amiodarone, tranylcypromine, precocene II, but not for 2-thiouracil"><entity charOffset="45-48" id="DDI-PubMed.10418968.s9.e0" text="MTT" /><entity charOffset="125-134" id="DDI-PubMed.10418968.s9.e1" text="tamoxifen" /><entity charOffset="136-145" id="DDI-PubMed.10418968.s9.e2" text="clozapine" /><entity charOffset="147-163" id="DDI-PubMed.10418968.s9.e3" text="cadmium chloride" /><entity charOffset="165-175" id="DDI-PubMed.10418968.s9.e4" text="diclofenac" /><entity charOffset="177-187" id="DDI-PubMed.10418968.s9.e5" text="amiodarone" /><entity charOffset="189-204" id="DDI-PubMed.10418968.s9.e6" text="tranylcypromine" /><entity charOffset="232-244" id="DDI-PubMed.10418968.s9.e7" text="2-thiouracil" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e0" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e1" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e2" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e3" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e4" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e5" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e0" e2="DDI-PubMed.10418968.s9.e7" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e1" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e2" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e3" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e4" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e5" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e1" e2="DDI-PubMed.10418968.s9.e7" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e2" e2="DDI-PubMed.10418968.s9.e2" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e2" e2="DDI-PubMed.10418968.s9.e3" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e2" e2="DDI-PubMed.10418968.s9.e4" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e2" e2="DDI-PubMed.10418968.s9.e5" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e2" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e2" e2="DDI-PubMed.10418968.s9.e7" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e3" e2="DDI-PubMed.10418968.s9.e3" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e3" e2="DDI-PubMed.10418968.s9.e4" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e3" e2="DDI-PubMed.10418968.s9.e5" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e3" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e3" e2="DDI-PubMed.10418968.s9.e7" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e4" e2="DDI-PubMed.10418968.s9.e4" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e4" e2="DDI-PubMed.10418968.s9.e5" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e4" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e4" e2="DDI-PubMed.10418968.s9.e7" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e5" e2="DDI-PubMed.10418968.s9.e5" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e5" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e5" e2="DDI-PubMed.10418968.s9.e7" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e6" e2="DDI-PubMed.10418968.s9.e6" /><pair ddi="false" e1="DDI-PubMed.10418968.s9.e6" e2="DDI-PubMed.10418968.s9.e7" /></sentence><sentence text=" Cell density- and time-dependent metabolism of 7-EC and dextromethorphan were observed in the HTS assay for metabolic stability"><entity charOffset="57-73" id="DDI-PubMed.10418968.s10.e0" text="dextromethorphan" /><entity charOffset="48-63" id="DDI-PubMed.10418968.s10.e1" text="7-EC" /><pair ddi="false" e1="DDI-PubMed.10418968.s10.e1" e2="DDI-PubMed.10418968.s10.e1" /><pair ddi="false" e1="DDI-PubMed.10418968.s10.e1" e2="DDI-PubMed.10418968.s10.e0" /></sentence><sentence text=" Known CYP isoform-specific inhibitors were evaluated in the HTS assay for inhibitory drug-drug interactions" /><sentence text=" Furafylline, sulfaphenazole, quinidine, and ketoconazole were found to be specific inhibitors of CYP1A2, CYP2C9, CYP2D6, and CYP3A4, respectively"><entity charOffset="1-12" id="DDI-PubMed.10418968.s12.e0" text="Furafylline" /><entity charOffset="14-28" id="DDI-PubMed.10418968.s12.e1" text="sulfaphenazole" /><entity charOffset="30-39" id="DDI-PubMed.10418968.s12.e2" text="quinidine" /><entity charOffset="45-57" id="DDI-PubMed.10418968.s12.e3" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e0" e2="DDI-PubMed.10418968.s12.e0" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e0" e2="DDI-PubMed.10418968.s12.e1" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e0" e2="DDI-PubMed.10418968.s12.e2" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e0" e2="DDI-PubMed.10418968.s12.e3" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e1" e2="DDI-PubMed.10418968.s12.e1" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e1" e2="DDI-PubMed.10418968.s12.e2" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e1" e2="DDI-PubMed.10418968.s12.e3" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e2" e2="DDI-PubMed.10418968.s12.e2" /><pair ddi="false" e1="DDI-PubMed.10418968.s12.e2" e2="DDI-PubMed.10418968.s12.e3" /></sentence><sentence text=" Tranylcypromine and diethyldithiocarbamate were found to be less specific, with inhibitory effects towards several CYP isoforms, including CYP2A6, CYP2C9, CYP2C19, and CYP2E1"><entity charOffset="1-16" id="DDI-PubMed.10418968.s13.e0" text="Tranylcypromine" /><entity charOffset="21-43" id="DDI-PubMed.10418968.s13.e1" text="diethyldithiocarbamate" /><pair ddi="false" e1="DDI-PubMed.10418968.s13.e0" e2="DDI-PubMed.10418968.s13.e0" /><pair ddi="false" e1="DDI-PubMed.10418968.s13.e0" e2="DDI-PubMed.10418968.s13.e1" /></sentence><sentence text=" These results suggest that cryopreserved human hepatocytes represent a useful experimental tool for the evaluation of drug metabolism, toxicity, and inhibitory drug-drug interaction potential" /><sentence text="" /></document>